Marcin Dada

Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial

Daniel S Berman, Mihaela Aslan, Paul Kolm, 2013, Circulation. Cardiovascular quality and outcomes.

Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients

Ron Goeree, Claudine Jurkovitz, Emir Veledar, 2008, Circulation. Cardiovascular quality and outcomes.